Prognostic value of elevated cardiac and inflammatory biomarkers in patients with severe COVID-19: a single-center, retrospective study
Emergency and Critical Care Medicine · 2022
DOI: 10.1097/ec9.0000000000000057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emergency and Critical Care Medicine, 2022. Verfasst von Neeraj Kumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Trauma and Emergency, All India Institute of Medical Sciences Patna, Bihar, India. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 in India has been declared a public health emergency. Many patients with COVID-19 experience cardiac injury. Patients with COVID-19 admitted to the intensive care unit (ICU) with acute myocardial injury showed increased high-sensitivity troponin levels. Abnormal troponin levels may indicate myocardial injury and are commonly associated with COVID-19.
Methods
We conducted a retrospective observational study of 44 patients with severe COVID-19 in ICU during the second wave. The primary end point of our retrospective study was 28-day mortality, and the time of ICU admission was designated as day 0. We extracted and analyzed cardiac biomarkers, such as creatine kinase (CK), creatine kinase-MB (CK-MB), B-type natriuretic peptide (BNP), and high-sensitivity cardiac troponin I (hs-cTnI), and various inflammatory markers such as C-reactive protein (CRP) level, interleukin 6 (IL-6), d -dimer, ferritin, lactate dehydrogenase, IL-6, and procalcitonin in patients with severe COVID-19 at ICU admission and 72 hours after ICU admission from our electronic medical record system.
Results
The best cutoff of BNP were 326.8 and 398.5 pg/mL, CK were 195.95 and 180.12 U/L, CK-MB were 112.10 and 108.5 U/L, and hs-cTnI were 0.035 and 0.025 ng/mL, at ICU admission and 72 hours after ICU admission for predicting 28-day mortality among nonsurvivors.
Conclusion
In patients with severe COVID-19, CK and hs-cTnI may be considered effective and valuable predictive cardiac biomarkers among nonsurvivors and predict poor prognosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Trauma and Emergency, All India Institute of Medical Sciences Patna, Bihar, India.
- Department of Anaesthesiology, All India Institute of Medical Sciences Patna, Bihar, India.
- Department of Biochemistry, All India Institute of Medical Sciences Patna, Bihar, India.
- Director, All India Institute of Medical Sciences Patna, Bihar, India.
Zitieren
APA
Kumar, N., Ahmad, S., Mahto, M., Kumar, A., & Singh, P. K. (2022). Prognostic value of elevated cardiac and inflammatory biomarkers in patients with severe COVID-19: a single-center, retrospective study. Emergency and Critical Care Medicine. https://doi.org/10.1097/ec9.0000000000000057
Vancouver
Kumar N, Ahmad S, Mahto M, Kumar A, Singh PK. Prognostic value of elevated cardiac and inflammatory biomarkers in patients with severe COVID-19: a single-center, retrospective study. Emergency and Critical Care Medicine. 2022. doi:10.1097/ec9.0000000000000057
BibTeX
@article{Kumar2022,
author = {Kumar, Neeraj and Ahmad, Sarfaraz and Mahto, Mala and Kumar, Abhyuday and Singh, Prabhat K},
title = {Prognostic value of elevated cardiac and inflammatory biomarkers in patients with severe COVID-19: a single-center, retrospective study},
journal = {Emergency and Critical Care Medicine},
year = {2022},
doi = {10.1097/ec9.0000000000000057}
}
EUVIMED